EVLV
Evolv Technologies Holdings, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- S Mar 2 to Mar 6 2 days of insider sells: $898.4K by 1 insider, avg $5.14
- S Jun 2 1 insider sell $425.2K at $6.85
- S Jun 15 1 insider sell $501.4K at $6.21
- S Jul 15 1 insider sell $479.6K at $5.94
- B Aug 14 2 insiders buy $134.7K at $5.73
- S Aug 17 1 insider sell $451.4K at $5.59
- B Sep 4 1 insider buy $161.7K at $4.96
- A Sep 8 Ladenburg Thalmann initiates
Signal stack
Where each data set points today.
- InsidersBEARISH
3 insiders bought $296.5K at an average $5.28. 3 insiders sold $4.1M. Price is 16% below their cost.
- InstitutionsMIXED
Q2 2026: 24 added (0 new), 22 trimmed or exited.
- AnalystsBULLISH
10 of 11 rate it Buy or better. Every target is above the price.
- EstimatesFALLING
Current-quarter EPS estimate −$0.020 → −$0.023 over 90 days. 0 up, 1 down in 30 days.
- TrendDOWNTREND
9% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| D. E. Shaw & Co., Inc. | DOUBLED | $28.1M |
| MORGAN STANLEY | ADD | $11.1M |
| GOLDMAN SACHS GROUP INC | ADD | $10.0M |
| Qube Research & Technologies Ltd | ADD | $9.5M |
| Trexquant Investment LP | ADD | $7.5M |
| Squarepoint Ops LLC | TRIM | $5.4M |
| JPMORGAN CHASE & CO | DOUBLED | $5.2M |
| UBS Group AG | ADD | $4.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
11 analystsPrice is below the lowest target. Median implies +126%.Targets as of Oct 27, 2026.
| Date | Firm | Rating |
|---|---|---|
| Sep 8, 2026 | Ladenburg Thalmann INITIATE | Buy |
| Jun 9, 2026 | TD Cowen REITERATE | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Sep 4, 2026 | Shapiro Richard A Director | BUY | $67.0K |
| Sep 4, 2026 | Shapiro Richard A Director | BUY | $32.2K |
| Sep 4, 2026 | Shapiro Richard A Director | BUY | $44.8K |
| Sep 4, 2026 | Shapiro Richard A Director | BUY | $17.8K |
| Aug 17, 2026 | Ellenbogen Michael Director | EXERCISE | $19.4K |
| Aug 17, 2026 | Ellenbogen Michael Director | SELL | $451.4K |
| Aug 14, 2026 | Glat Neil Director | BUY | $48.8K |
| Aug 14, 2026 | Kuhl Henrik Director | BUY | $86.0K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.02 | -$0.03–-$0.02 | +0.0% | $45.6M |
| Next Q | -$0.02 | -$0.02–-$0.01 | +0.0% | $46.7M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026SecBot reports
4 filings · 1 bullish · 0 bearish · 3 neutral- NEUTRAL INSIDER-BUYSep 9, 2026
Director Richard Shapiro purchased 29,000 shares of Evolv Technologies for ~$162K at ~$4.96/share…
The director's buy is a modest positive signal but lacks the scale or C-suite participation to be a strong catalyst. Monitor for any C-suite purchases or a material increase in buy volume; the…
- NEUTRAL CLUSTERAug 19, 2026
A mixed insider cluster at Evolv Technologies: two directors (Kuhl and Glat) made open-market…
The Ellenbogen sale is fully explained by option exercise and tax-related disposition — not a bearish signal. The two director purchases, while small in absolute terms, are voluntary cash…
- BULLISH CLUSTERAug 18, 2026
Two directors of Evolv Technologies purchased a combined $135K in open-market shares on August 14…
The coordinated open-market purchases by two independent directors, both at the same price level on the same day, suggest board-level conviction that the stock is undervalued. Monitor for any…
- NEUTRAL 8-KAug 10, 2026
The U.S. District Court for the District of Massachusetts preliminarily approved the settlement of…
The derivative settlement removes a significant overhang from Evolv's stock by resolving shareholder litigation without any direct cost to the company. Monitor the final approval hearing scheduled…
All EVLV filing & press-release reports (4)
- INSIDER-BUY reportSep 9, 2026
- CLUSTER reportAug 19, 2026
- CLUSTER reportAug 18, 2026
- 8-K reportAug 10, 2026